Scientific Advisory Board
Dr. Aguzzi is a Professor and Director of the Institute of Neuropathology at the University Hospital of Zurich. Dr. Aguzzi is a Founder and Director of the Swiss National Center for Prion Diseases and a former Governor of the Swiss Federal School of Technology.
Dr. Cashman is a Professor and Canada Research Chair in the Brain Research Center at the University of British Columbia. Dr. Cashman holds the position of Scientific Director at PrioNet Canada, a Network of Centres of Excellence for research into prions and prion diseases.
Dr. Siber is the Executive Chairman of Genocea Biosciences. Dr. Siber previously has held the position of Chief Scientific Officer and Executive Vice President of Wyeth Vaccines.
Dr. Yednock was most recently Executive Vice President and Head of Global Research for Elan Pharmaceuticals. Previously, Dr. Yednock was with Athena Neurosciences, where he initiated research on cell adhesion and multiple sclerosis that led to the development of Tysabri®, a monoclonal antibody with 2013 global in-market commercial sales of $1.7 billion.